A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

< b > Condition < /b > :   Avian Influenza < br/ > < b > Interventions < /b > :   Biological: aH5N1c;   Biological: Placebo < br/ > < b > Sponsors < /b > :   Seqirus;   Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials